Summary
Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- Biotechnology market encompasses a broad range of technologies, products, and services that utilize biological systems, organisms, or derivatives to develop or modify processes or products for specific applications. Market value refers to the revenue generated from product sales, licensing fees, royalties, and research funding.
- The Japanese biotechnology market recorded revenues of $54.3 billion in 2024, representing a compound annual growth rate (CAGR) of 11.5% between 2019 and 2024.
- The medical/healthcare segment accounted for the market's largest proportion in 2024, with total revenues of $23.8 billion, equivalent to 43.8% of the market's overall value.
- The growth of the Japanese biotechnology market is driven by the country’s proactive approach to regulating stem cell-based embryo models (SCBEMs).
Scope
- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts
Reasons to Buy
- What was the size of the Japan biotechnology market by value in 2024?
- What will be the size of the Japan biotechnology market in 2029?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?
'
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key players?
7.2. What strategies do the key players follow?
7.3. What have been the most recent market developments?
8 Company Profiles
8.1. Takeda Pharmaceutical Co Ltd
8.2. Astellas Pharma Inc
8.3. Kyowa Kirin Co Ltd
8.4. Chugai Pharmaceutical Co Ltd
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. About MarketLine
List of Tables
Table 1: Japan biotechnology industry value: $ million, 2019-24
Table 2: Japan biotechnology industry category segmentation: % share, by value, 2019-24
Table 3: Japan biotechnology industry category segmentation: $ million, 2019-24
Table 4: Japan biotechnology industry geography segmentation: $ million, 2024
Table 5: Japan biotechnology industry value forecast: $ million, 2024-29
Table 6: Takeda Pharmaceutical Co Ltd: Key Facts
Table 7: Takeda Pharmaceutical Co Ltd: Annual Financial Ratios
Table 8: Takeda Pharmaceutical Co Ltd: Key Employees
Table 9: Astellas Pharma Inc: Key Facts
Table 10: Astellas Pharma Inc: Annual Financial Ratios
Table 11: Astellas Pharma Inc: Key Employees
Table 12: Kyowa Kirin Co Ltd: Key Facts
Table 13: Kyowa Kirin Co Ltd: Annual Financial Ratios
Table 14: Kyowa Kirin Co Ltd: Key Employees
Table 15: Kyowa Kirin Co Ltd: Key Employees Continued
Table 16: Chugai Pharmaceutical Co Ltd: Key Facts
Table 17: Chugai Pharmaceutical Co Ltd: Annual Financial Ratios
Table 18: Chugai Pharmaceutical Co Ltd: Key Employees
Table 19: Japan Size of Population (Million), 2019-24
Table 20: Japan Real GDP (Constant 2010 Prices, $ Billion), 2019-24
Table 21: Japan GDP (Current Prices, $ Billion), 2019-24
Table 22: Japan Inflation, 2019-24
Table 23: Japan Consumer Price Index (Absolute), 2019-24
Table 24: Japan Exchange Rate, 2019-24
List of Figures
Figure 1: Japan biotechnology industry value: $ million, 2019-24
Figure 2: Japan biotechnology industry category segmentation: $ million, 2019-24
Figure 3: Japan biotechnology industry geography segmentation: % share, by value, 2024
Figure 4: Japan biotechnology industry value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the biotechnology industry in Japan, 2024
Figure 6: Drivers of buyer power in the biotechnology industry in Japan, 2024
Figure 7: Drivers of supplier power in the biotechnology industry in Japan, 2024
Figure 8: Factors influencing the likelihood of new entrants in the biotechnology industry in Japan, 2024
Figure 9: Factors influencing the threat of substitutes in the biotechnology industry in Japan, 2024
Figure 10: Drivers of degree of rivalry in the biotechnology industry in Japan, 2024
